We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Enzo Biochem Life Sciences Unit Awarded Patent for Increasing Detectability of Proteins and Pathogens
News

Enzo Biochem Life Sciences Unit Awarded Patent for Increasing Detectability of Proteins and Pathogens

Enzo Biochem Life Sciences Unit Awarded Patent for Increasing Detectability of Proteins and Pathogens
News

Enzo Biochem Life Sciences Unit Awarded Patent for Increasing Detectability of Proteins and Pathogens

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Enzo Biochem Life Sciences Unit Awarded Patent for Increasing Detectability of Proteins and Pathogens"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Enzo Biochem, Inc. announces that its subsidiary, Enzo Life Sciences, Inc., has been granted a new patent by the U.S. Patent and Trademark Office that will complement existing proprietary technologies that have applications in the molecular diagnostics and life sciences marketplaces.

“The addition of this patent to our growing intellectual property portfolio adds to the growing line of products and technology we are providing to the medical research establishment worldwide,” said Elazar Rabbani, Ph.D., Chairman and CEO, and the lead inventor on the patent. “These patents have applications that can potentially enhance the visualization of minute quantities of biological material, which in turn, can lead to more sensitive diagnostic assays.”

Patent #7,514,551 entitled “Multisignal Labeling Reagents and Processes and Uses Therefor”, covers the use of labeled nucleotides that when linked to other biological molecules such as proteins, provide enhanced signals and solubility, thus rendering them more readily detectable. Such technology can have wide ranging uses in the development of next generation of diagnostic kits.
Advertisement